Know Cancer

or
forgot password

Combined Application of EBUS-TBNA and EUS-B-FNA in Mediastinal Staging of Lung Cancer; EBUS-TBNA Centered Procedure vs. EUS-B-FNA Centered Procedure, a Randomized Study.


N/A
18 Years
N/A
Not Enrolling
Both
Non Small Cell Lung Cancer

Thank you

Trial Information

Combined Application of EBUS-TBNA and EUS-B-FNA in Mediastinal Staging of Lung Cancer; EBUS-TBNA Centered Procedure vs. EUS-B-FNA Centered Procedure, a Randomized Study.


Inclusion Criteria:



- Histologically confirmed or strongly suspected non-small cell lung cancer (NSCLC)

- Potentially operable patients

Exclusion Criteria:

- M1 disease

- Inoperable T4 disease

- Mediastinal infiltration or extranodal invasion of the mediastinal lymph node visible
on chest CT.

- Confirmed supraclavicular lymph node metastasis

- Pancoast tumors

- Medically inoperable patients

- Contraindications for bronchoscopy and esophageal endoscopy

- Drug reaction to lidocaine, midazolam,fentanyl

- Pregnancy

- Ground glass-dominant nodule ( < 3cm)

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic

Outcome Measure:

Diagnostic accuracy

Outcome Time Frame:

When the confimative disgnosis is available in all subjects (after surgery) ; 8-12 months

Safety Issue:

No

Principal Investigator

Bin Hwangbo, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Medical Doctor, Senior Researcher

Authority:

Korea: Institutional Review Board

Study ID:

NCC-EUSEBUS

NCT ID:

NCT01385111

Start Date:

June 2011

Completion Date:

February 2012

Related Keywords:

  • Non Small Cell Lung Cancer
  • endobronchial ultrasound
  • endoscopic ultrasound
  • EBUS-TBNA
  • EUS-FNA
  • EUS-B-FNA
  • lung cancer
  • staging
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location